This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Tel Aviv University, Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Innovations in Pulmonary Treatment by Gil Sokol
Introduction
Gil Sokol is an inventor based in Ganey-Tikva, Israel, known for his contributions to respiratory therapy. He holds a patent for devices and methods aimed at treating lung diseases, showcasing his commitment to improving patient care in this critical area.
Latest Patents
Sokol's patent, titled "Devices and methods for treating lung diseases," focuses on pulmonary treatment methods and systems. The invention emphasizes the importance of breath cycles during pulmonary treatment, where a hold period of elevated inspiration pressure can enhance lung region filling through collateral airways. The method also promotes expectoration by adjusting the inspiration pressure and mitigating de-recruitment during the expiration phase. The system includes a hand-held unit with a patient mouthpiece, a base unit providing pressurized gas, and an electronically controllable valve for therapy maneuvers such as Positive Expiratory Pressure (PEP).
Career Highlights
Throughout his career, Gil Sokol has worked with notable organizations, including Tel Hashomer Medical Research Infrastructure and Services Ltd. and Ramot at Tel Aviv University Ltd. His experience in these institutions has contributed to his expertise in respiratory therapies and innovations.
Collaborations
Sokol has collaborated with professionals such as Moshe Ashkenazi and Ori Efrati, further enhancing his work in the field of pulmonary treatment.
Conclusion
Gil Sokol's innovative approach to treating lung diseases through his patented methods and devices highlights his significant contributions to respiratory therapy. His work continues to impact the field positively, offering new solutions for patients with lung conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile